Q&A: A Fresh Perspective from the FDA on the Final IND Safety Reporting Rule

June 22, 2021
Previous Flipbook
The Challenge of Overreporting: A Fresh Perspective from the FDA
The Challenge of Overreporting: A Fresh Perspective from the FDA

In a recent webinar, Steven Beales, Senior VP, Scientific and Regulatory at WCG, facilitated a conversation...

Next Video
A Fresh Perspective from the FDA on the Final IND Safety Reporting Rule
A Fresh Perspective from the FDA on the Final IND Safety Reporting Rule

A Fresh Perspective from the FDA on the Final IND Safety Reporting Rule